(Q54594046)

1 June 2018

title

Expression and function role of DNA methyltransferase 1 in human bladder cancer. (English)

1 reference

1 June 2018

author name string

Chun-Te Wu

1

1 reference

1 June 2018

Ching-Fang Wu

2

1 reference

1 June 2018

Chang-Hsien Lu

3

1 reference

1 June 2018

Cheng-Chia Lin

4

1 reference

1 June 2018

Wen-Cheng Chen

5

1 reference

1 June 2018

Paul-Yang Lin

6

1 reference

1 June 2018

Miao-Fen Chen

7

1 reference

1 June 2018

language of work or name

English

0 references

publication date

26 April 2011

1 reference

1 June 2018

published in

Cancer

1 reference

1 June 2018

volume

117

1 reference

1 June 2018

page(s)

5221-5233

1 reference

1 June 2018

issue

22

1 reference

1 June 2018

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Trimodality treatment and selective organ preservation for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Updated results of bladder-sparing trimodality approach for invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

DNA methylation and chromatin - unraveling the tangled web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The DNA methyltransferases of mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Biochemistry and biology of mammalian DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The promises and pitfalls of epigenetic therapies in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The role of apoptosis in cancer development and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Alterations of DNA methylation and clinicopathological diversity of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Role of DNA methyltransferase 1 in hormone-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Growth factors and receptors as prognostic markers in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

The PI3K pathway as drug target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Pathways of apoptotic and non-apoptotic death in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Phosphorylation of histone H2AX as a measure of radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

7 January 2021

Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

7 January 2021

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26150

7 January 2021

Identifiers

DOI

10.1002/CNCR.26150

1 reference

1 June 2018

PubMed ID

21523767

1 reference

1 June 2018